BMRN Biomarin Pharmaceutical
- 81.970
- +1.060+1.31%
Biomarin Pharmaceutical News
US MOVERS&SHAKERS Apr 22-Apr 26, 2024
Here are the top 10 gainers and losers of the week.
BioMarin Pharmaceutical Price Target Cut to $112.00/Share From $115.00 by Morgan Stanley
BioMarin Pharmaceutical Price Target Cut to $112.00/Share From $115.00 by Morgan Stanley
Biomarin Pharmaceutical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 37.05% Morgan Stanley $115 → $112 Maintains Overweight 04/26/2024 8.91% Canaccord Genuity $91 →
BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity
BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Express News | Canaccord Genuity Maintains Hold on Biomarin Pharmaceutical, Lowers Price Target to $89
Results: BioMarin Pharmaceutical Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shareholders are probably feeling a little disappointed, since its shares fell 8.8% to US$82.17 in the week after its latest quarterly results. It look
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Earnings and Voxzogo's Growth Potential
Top Gap Ups and Downs on Thursday: META, AZN, CAT and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup
BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup
Express News | Citigroup Maintains Neutral on Biomarin Pharmaceutical, Lowers Price Target to $91
BioMarin Pharmaceutical Down Over 8%, on Pace for Largest Percent Decrease Since January 2021 -- Data Talk
BioMarin Pharmaceutical Inc. (BMRN) is currently at $83.42, down $7.78 or 8.53% --Would be lowest close since Nov. 13, 2023, when it closed at $83.39 --On pace for largest percent decrease since Jan
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
In the preceding three months, 8 analysts have released ratings for Biomarin Pharmaceutical (NASDAQ:BMRN), presenting a wide array of perspectives from bullish to bearish.The table below provides a co
Express News | Cantor Fitzgerald Reiterates Overweight on Biomarin Pharmaceutical, Maintains $110 Price Target
BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo
BioMarin Pharmaceutical Is Maintained at Overweight by Wells Fargo
Express News | Biomarin Pharmaceutical Shares Down 8.1% After Q1 Rev Miss
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Universal Health (UHS)
Scotiabank Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
Analysis
Price Target
No Data
